Here is how most equipment decisions actually unfold in a manufacturing company: operations picks the machine, finance figures out how to fund it, and tax gets consulted sometime in the fourth quarter — if at all. That sequence costs manufacturers real money.
Financing structure and tax treatment are not independent variables. The method you use to acquire equipment determines when and whether you can deduct it, how it appears on your balance sheet, and what your effective after-tax cost actually is. For CFOs and finance leaders managing capital expenditures in a manufacturing environment, those distinctions are material.
This article lays out the primary financing options, the tax mechanics attached to each, and the planning moves worth making right now.
The One Big Beautiful Bill Act, signed July 4, 2025, made two significant amendments to the Internal Revenue Code that directly affect manufacturers:
Section 179 expensing now allows businesses to immediately deduct up to $2.5 million in qualifying property placed in service in tax years beginning after December 31, 2024 — up from $1.25 million previously. The phase-out threshold was raised to $4 million, meaning the deduction reduces dollar-for-dollar only once total qualifying purchases exceed that threshold and disappears entirely at $6.5 million.
Bonus depreciation was restored to 100% for qualifying assets acquired and placed in service after January 19, 2025. This reverses the scheduled phase-down that had brought the rate to 60% in 2024. Unlike Section 179, bonus depreciation carries no taxable income limitation — it can generate or increase a net operating loss, which may then be carried forward under applicable rules.
Both incentives apply to tangible property with a recovery period of 20 years or less — machinery, equipment, and most manufacturing assets qualify. Equipment must be placed in service (installed and available for its intended use) before the last day of the tax year to qualify for that year’s deductions.
Here are the three financing structure options and how they play out in terms of taxes.
When a manufacturer purchases equipment outright — whether through a term loan, an equipment financing arrangement, or internal cash — the business holds title from day one. That matters for tax purposes: the purchaser claims depreciation.
Under current law, a manufacturer purchasing $1.5 million in qualifying production equipment in 2025 could elect to deduct the full cost under Section 179 in the current year, subject to the taxable income limitation. If Section 179 is unavailable or insufficient, 100% bonus depreciation provides a comparable result without the income cap.
The practical implication: A 25% effective tax rate on a $1.5 million deduction produces approximately $375,000 in current-year tax savings. The equipment’s after-tax cost is $1.125 million before financing costs.
A capital lease — formally classified as a finance lease under ASC 842 — transfers substantially all risks and rewards of ownership to the lessee. The lessee records both an asset and a corresponding liability on the balance sheet, and critically, the lessee claims depreciation on that asset.
This means that Section 179 and bonus depreciation are available for financed equipment, just as with a direct purchase. The IRS confirms that property acquired under a financing arrangement and placed in service qualifies for expensing elections — the obligation to make future payments does not disqualify the asset.
The balance sheet impact — an increase in both assets and liabilities — should be factored into covenant compliance analysis before execution.
Many manufacturers overlook the Research and Development tax credit because they do not consider themselves research companies. The standard is considerably broader than most assume.
Under IRC Section 41, manufacturers may qualify for R&D credits when they attempt to develop or improve a product, process, formula, or software — including improving manufacturing processes, reducing production costs, or increasing yield. The credit is calculated as a percentage of qualified research expenditures, which can include wages paid to employees conducting qualifying activities, certain contractor costs, and some supply costs directly related to the research.
The manufacturing industry claims more than $7.4 billion in annual R&D credits (IRS Statistics of Income data). That figure exists because the activity threshold is functional, not theoretical — process improvement counts.
Unlike a deduction, the R&D credit reduces tax liability dollar-for-dollar. It operates independently of equipment financing decisions and can be applied in the same year as a major equipment purchase.
Section 179, bonus depreciation, and R&D credits each reduce tax liability through distinct mechanisms with distinct rules. Applied in isolation, each provides value. Coordinated as part of a capital expenditure plan, the combined effect is substantially greater.
The sequencing matters: Section 179 must be applied before bonus depreciation. Bonus depreciation has no income floor. The R&D credit can be applied against the tax liability that remains after deductions reduce taxable income. Understanding the interaction between these tools — and the correct order of operations — is where tax planning for manufacturers produces measurable results.
At Wiss, our manufacturing and distribution practice works with CFOs, controllers, and business owners to structure equipment acquisitions with full tax visibility before the transaction closes, not after. If your company is planning capital expenditures in 2026 or evaluating a financing arrangement, now is the time to model the tax position.
The information in this article reflects federal tax law as of the date of publication. State tax treatment varies and should be evaluated separately. Consult a qualified tax advisor before making financing or tax elections.